Evidence map›Paper›PMID 40439173›Full record

ArticleAnalytical chemistry2025

Improvements in Glycoproteomics through Architecture Changes to the Orbitrap Tribrid MS Platform.

Tim S Veth, Emmajay Sutherland, Kayla A Markuson, Ruby Zhang, Anna G Duboff, Jingjing Huang, David Bergen, Amanda E Lee, Rafael D Melani, Jesse D Canterbury and 4 more

Abstract read
In one paragraph

Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. UnderstandingJournal of the American Society for Mass Spectrometry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Tim S VethDepartment of Chemistry, University of Washington, Seattle 98195, Washington, United States.ORCID 0000-0002-2561-5437
Emmajay SutherlandDepartment of Chemistry, University of Washington, Seattle 98195, Washington, United States.ORCID 0000-0001-5150-4346
Kayla A MarkusonDepartment of Chemistry, University of Washington, Seattle 98195, Washington, United States.
Ruby ZhangDepartment of Chemistry, University of Washington, Seattle 98195, Washington, United States.
Anna G DuboffDepartment of Chemistry, University of Washington, Seattle 98195, Washington, United States.ORCID 0009-0002-7316-3831
Jingjing HuangThermo Fisher Scientific, San Jose 95134, California, United States.
David BergenThermo Fisher Scientific, San Jose 95134, California, United States.
Amanda E LeeThermo Fisher Scientific, San Jose 95134, California, United States.
Rafael D MelaniThermo Fisher Scientific, San Jose 95134, California, United States.
Jesse D CanterburyThermo Fisher Scientific, San Jose 95134, California, United States.
Vlad ZabrouskovThermo Fisher Scientific, San Jose 95134, California, United States.ORCID 0000-0003-3567-9407
Graeme C McAlisterThermo Fisher Scientific, San Jose 95134, California, United States.
Christopher MullenThermo Fisher Scientific, San Jose 95134, California, United States.
Nicholas M RileyDepartment of Chemistry, University of Washington, Seattle 98195, Washington, United States.ORCID 0000-0002-1536-2966

Funding

TR&D 2 Metabolic Labels for Ultraplexed Protein Quantification p. 453P41GM108538 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI COON, JOSHUA J · 2016 to 2025
$13.1M
Capturing the Holistic Glycocode through Systems GlycobiologyR00GM147304 · NIGMS · UNIVERSITY OF WASHINGTON · PI Nicholas M Riley · 2024 to 2026
$747k
NIGMS NIH HHS P41 GM108538NIGMS NIH HHS R00 GM147304
6 · The paper itself

Abstract

Hardware changes introduced on the Orbitrap Ascend Tribrid MS include dual ion routing multipoles (IRMs) that enable parallelized accumulation, dissociation, and Orbitrap mass analysis of three separate ion populations. The balance between these instrument functions is especially important in glycoproteomics, where complexities of glycopeptide fragmentation necessitate large precursor ion populations and long ion accumulation times for quality MS/MS spectra. To compound matters further, dissociation methods like electron transfer dissociation (ETD) that benefit glycopeptide characterization come with overhead times that slow down scan acquisition. Here we explored how the Orbitrap Ascend's dual IRM architecture can improve glycopeptide analysis, with a focus on O-glycopeptide characterization using ETD with supplemental collisional activation (EThcD). We found that parallelization of ion accumulation and EThcD fragmentation increased scan acquisition speed without sacrificing spectral quality, subsequently increasing the number of O-glycopeptides identified relative to analyses on the Orbitrap Eclipse (i.e., the previous generation Tribrid MS). Additionally, we systematically evaluated ion-ion reaction times and supplemental activation energies used for EThcD to understand how best to utilize acquisition time. We observed that shorter-than-expected ion-ion reaction times minimized scan overhead time without sacrificing

Indexed as

GlycopeptidesProteomicsTandem Mass SpectrometryGlycopeptides

Identifiers

PMID40439173
PMCPMC13185084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.